Ashwin Ragupathi
Impact in
-
- Radiopharmaceutical Chemistry and Applications
-
- HER2/EGFR in Cancer Research
- PARP inhibition in cancer therapy
Papers in
-
- Radiopharmaceutical Chemistry and Applications 6
- Oncology 4
- HER2/EGFR in Cancer Research 3
- Co-authors
- Jason Stuart Lewis (9 shared papers)Patrícia M. R. Pereira (5 shared papers)Komal Mandleywala (5 shared papers)Lukas Carter (3 shared papers)Yelena Yuriy Janjigian (3 shared papers)Dong Zhang (3 shared papers)Manrose Singh (2 shared papers)R. Brian Dyer (2 shared papers)
- Journals
- Clinical Cancer Research (2 papers)Nature Communications (2 papers)Bioconjugate Chemistry (2 papers)Molecular Pharmaceutics (1 paper)Frontiers in Cell and Developmental Biology (1 paper)
- Partner nations
- United States
In The Last Decade
Ashwin Ragupathi
15 papers receiving 506 citations
Peers
Comparison fields: 5 of 54
- Radiology, Nuclear Medicine and Imaging 198
- Oncology 113
- Cell Biology 40
- Cancer Research 38
- Biomaterials 23
Countries citing papers authored by Ashwin Ragupathi
This map shows the geographic impact of Ashwin Ragupathi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ashwin Ragupathi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ashwin Ragupathi more than expected).
Fields of papers citing papers by Ashwin Ragupathi
This network shows the impact of papers produced by Ashwin Ragupathi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ashwin Ragupathi. The network helps show where Ashwin Ragupathi may publish in the future.
Co-authors
The 25 scholars most cited alongside Ashwin Ragupathi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 109 | |
| 2 | 2018 | 85 | |
| 3 | 2023 | 76 | |
| 4 | 2018 | 50 | |
| 5 | 2018 | 46 | |
| 6 | 2022 | 36 | |
| 7 | 2019 | 30 | |
| 8 | 2020 | 27 | |
| 9 | 2019 | 21 | |
| 10 | 2021 | 14 | |
| 11 | 2023 | 8 | |
| 12 | 2023 | 6 | |
| 13 | 2020 | 5 | |
| 14 | 2024 | 2 | |
| 15 | 2020 | 1 | |
| 16 | 2025 | 0 |
About Ashwin Ragupathi
Ashwin Ragupathi is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology, Cell Biology, Urology and Reproductive Medicine, having authored 16 papers that have together received 516 indexed citations. Recurring topics across this work include Radiopharmaceutical Chemistry and Applications (6 papers), HER2/EGFR in Cancer Research (3 papers), Robotic Locomotion and Control (2 papers), Caveolin-1 and cellular processes (2 papers), Comparative Animal Anatomy Studies (1 paper), Telomeres, Telomerase, and Senescence (1 paper), Protein Structure and Dynamics (1 paper) and Ovarian cancer diagnosis and treatment (1 paper). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (198 citations), Oncology (113 citations), Cell Biology (40 citations), Cancer Research (38 citations) and Biomaterials (23 citations). Ashwin Ragupathi has collaborated with scholars based in United States. Frequent co-authors include Jason Stuart Lewis, Patrícia M. R. Pereira, Komal Mandleywala, Lukas Carter, Yelena Yuriy Janjigian, Dong Zhang, Manrose Singh, R. Brian Dyer, Brian M. Zeglis and Wolfgang W. Scholz. Their work appears in journals such as Clinical Cancer Research, Nature Communications, Bioconjugate Chemistry, Molecular Pharmaceutics and Frontiers in Cell and Developmental Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.